![]() |
市场调查报告书
商品编码
1887118
桌上型超音波设备市场规模、占有率、成长及全球产业分析:依类型、应用和地区划分的洞察,以及2024-2032年预测Table-top Ultrasound Equipment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
2024年,全球桌上型超音波设备市场维持成长势头,达到66.3亿美元。预计该市场将稳定成长,到2025年达到69.5亿美元,到2032年达到96亿美元,2025年至2032年的复合年增长率(CAGR)为4.7%。这一增长主要得益于对先进诊断成像需求的不断增长、慢性病患病率的上升以及超音波系统技术的不断创新。 2024年,亚太地区以43.74%的市占率占主导地位,这主要得益于其庞大的人口基数、不断完善的医疗基础设施以及快速老化的人口结构。
主要市场驱动因子
该市场的主要推动力是全球对诊断影像的需求不断增长,而这又源于急慢性疾病盛行率的上升。心血管疾病、癌症、泌尿系统疾病和妇科併发症等疾病正在推动全球诊断率的提高。根据美国癌症协会(2024 年)预测,2024 年新增癌症病例约 200 万例,这将显着增加对先进影像工具的需求。
亚太地区,尤其是中国,拥有庞大的病患群体,需要诊断服务。根据中国政府 2024 年的报告,中国 60 岁以上老年人口达 2.97 亿人。随着人口老化,超音波检查的数量不断增加,从而推动了对可靠、高品质诊断的需求。桌上型超音波系统以其卓越的影像清晰度和在临床应用中的多功能性而闻名,正成为医院和诊断中心的首选。
同时,西门子医疗、通用电气医疗、飞利浦医疗和佳能医疗系统等主要市场参与者正大力投资研发,以推出能够提高影像精度的创新产品。这种稳定的技术进步正在加速全球医疗系统对这些产品的采用。
市场限制因子
桌上型超音波系统成本高是市场扩张的主要障碍。根据富士软片Sonosite发布的2025年报告,新系统的价格将在5万美元至15万美元之间。这限制了其普及,尤其是在医疗预算有限的新兴国家。此外,快速成长的二手超音波系统市场也对新设备製造商构成了竞争挑战。二手系统的售价低至每台5000美元至15000美元。
市场机会
随着超音波影像在医疗保健领域的应用不断扩展,市场机会也日益显着。桌上型超音波系统在心臟科、妇科、肿瘤学、急诊医学和内科等领域的应用,使其成为重要的诊断工具。此外,床边超音波(POCUS)也正迅速普及。根据GE医疗(2023)报告,POCUS在诊断腹主动脉瘤方面具有98-100%的特异性,使其成为急诊诊断的关键工具。
3D和4D超音波技术的日益普及,以及人工智慧(AI)在成像平台中整合度的不断提高,持续为系统升级和新产品发布创造机会。
市场趋势
影响市场的一个显着趋势是转向技术先进的成像设备。高阶机型提供卓越的解析度、基于人工智慧的影像增强、远距医疗功能和先进的后处理功能。 2024年,富士软片推出了ALOKA ARIETTA 850,标誌着业界正向更聪明的诊断系统转型。此外,三星于2024年推出的HERA Z20系统进一步巩固了该公司在妇产科影像领域的地位。
2024年,3D超音波细分市场引领市场,这主要得益于心臟病学和妇科领域对精细可视化影像日益增长的需求。在妇科领域,由于异位妊娠和骨盆腔癌等疾病的高发生率,3D超音波的应用持续成长。
依终端用户划分,由于等待时间缩短、就诊更便捷以及提供专业的影像服务,诊断影像中心预计将显着增长。预计到 2023 年,光是美国就将拥有 19,000 个影像中心,以支撑较高的设备利用率。
亚太地区
预计到 2024 年,该地区市场规模将达到 29 亿美元。中国、日本和印度凭藉其高疾病盛行率、庞大的患者群体以及快速的技术应用,将继续保持领先地位。
北美
强劲的医疗保健支出、有利的报销机制以及持续的产品创新(包括 GE 医疗于 2024 年收购 AI)正在推动该地区的成长。
欧洲
高人均医疗保健支出和诊断技术的早期应用正在推动对桌上型超音波系统的持续高需求。
The global table-top ultrasound equipment market continued its upward trajectory in 2024, reaching a valuation of USD 6.63 billion. The market is projected to grow steadily to USD 6.95 billion in 2025 and further to USD 9.60 billion by 2032, reflecting a CAGR of 4.7% from 2025 to 2032. This growth is driven by the increasing need for advanced diagnostic imaging, rising chronic disease prevalence, and expanding technological innovations in ultrasound systems. In 2024, Asia Pacific dominated the market with a share of 43.74%, driven by its large population, expanding healthcare infrastructure, and rapidly aging demographic.
Key Market Drivers
The market is primarily driven by the increasing prevalence of acute and chronic disorders, which has elevated the global demand for diagnostic imaging. Conditions such as cardiovascular diseases, cancer, urological disorders, and gynecological complications are prompting higher diagnosis rates worldwide. According to the American Cancer Society (2024), approximately 2.0 million new cancer cases were expected in the U.S. in 2024, significantly raising the need for advanced imaging tools.
Asia Pacific, particularly China, shows a substantial patient base requiring diagnostic services, with 297 million adults aged 60 and above as reported by the Government of China in 2024. The aging demographic results in escalating ultrasound scans and an increasing need for reliable, high-quality diagnosis. Table-top ultrasound systems, known for superior image clarity and versatile use across clinical applications, are becoming the preferred choice for hospitals and diagnostic centers.
Simultaneously, leading market players such as Siemens Healthineers AG, GE Healthcare, Philips Healthcare, and Canon Medical Systems are investing heavily in R&D to launch innovative products that deliver enhanced imaging accuracy. This consistent technological progress is accelerating adoption across global healthcare systems.
Market Restraints
The major barrier to market expansion is the high cost associated with table-top ultrasound equipment. New systems can cost between USD 50,000 and USD 150,000, as reported by FUJIFILM Sonosite in 2025. This restricts adoption mainly in emerging economies, where healthcare budgets remain constrained. Additionally, the rapid expansion of the refurbished ultrasound equipment market-priced as low as USD 5,000 to USD 15,000 per system-presents a competitive challenge for manufacturers of new devices.
Market Opportunities
The market presents significant opportunities due to the expanding medical applications of ultrasound imaging. The integration of table-top ultrasound systems in cardiology, gynecology, oncology, emergency medicine, and internal medicine has positioned these devices as essential diagnostic tools. Furthermore, point-of-care ultrasound (POCUS) is gaining widespread adoption. According to GE Healthcare (2023), POCUS demonstrated 98-100% specificity in diagnosing abdominal aortic aneurysms, making it a vital tool in emergency diagnostics.
The increasing adoption of 3D and 4D ultrasound technologies and the growing integration of artificial intelligence (AI) within imaging platforms continue to create opportunities for system upgrades and new product launches.
Market Trends
A prominent trend shaping the market is the shift toward technologically advanced imaging equipment. High-end models now offer superior resolution, AI-based image enhancement, telemedicine readiness, and advanced post-processing capabilities. In 2024, FUJIFILM introduced the ALOKA ARIETTA 850, demonstrating the industry's pivot toward smarter diagnostic systems. Furthermore, Samsung's HERA Z20 system, launched in 2024, strengthened the company's position in the OB/GYN imaging field.
In 2024, the 3D ultrasound segment led the market due to rising demand for detailed visualization in cardiology and gynecology. In gynecological applications, the prevalence of conditions such as ectopic pregnancies and pelvic cancers continues to drive adoption.
Among end-users, diagnostic imaging centers are projected to grow significantly due to shorter wait times, accessibility, and specialized imaging services. The U.S. alone had 19,000 imaging centers in 2023, supporting high device utilization.
Asia Pacific
The region generated USD 2.90 billion in 2024, maintaining dominance due to high disease prevalence, large patient volume, and rapid technological adoption in China, Japan, and India.
North America
Strong healthcare spending, favorable reimbursement systems, and continuous product innovations-such as GE Healthcare's 2024 AI acquisition-propel regional growth.
Europe
High per capita healthcare expenditure and early adoption of diagnostic technologies sustain substantial demand for table-top ultrasound systems.
Conclusion
The table-top ultrasound equipment market will continue to expand from USD 6.63 billion in 2024 to USD 9.60 billion by 2032, supported by rising chronic disease burden, diagnostic advancements, and technological innovation. Asia Pacific remains the global growth engine, while North America and Europe continue to adopt new-generation systems at a strong pace.
Segmentation By Type
By Application
By End-user
By Region